2017 American Transplant Congress Archives - Page 14 of 181

P-LKDPI: A Donor Risk Index for Pediatric Recipients of Living Donor Kidney Transplantation.

A. Massie, N. Desai, A. Neu, D. Segev.
Pancreas Organ Underutilization: 15-Year Analysis.

S. Siddiqi, J. Almario, K. Villaroel-Gomez, J. Yoo, C. Blackburn, R. Batra, D. DiSabato, A. Lu, S. Akkina, A. Desai, R. Garcia-Roca.
Pancreas Transplant with Duodeno-Duodenostomy and Caval Drainage Using a Diamond Patch Graft: A Single-Center Experience.

B. Choi, T. Lee, Y. Park, K. Yang, C. Chu, J. Ryu, B. Choi.
Pancreatectomy and Islet Autotransplantation After Combined Split Liver Transplantation and Pancreaticoduodenectomy: A Case Report.

R. Horneland,¹ S. Guvåg,¹ O. Korsgren,² E. Aandahl.¹
Patency of Autologous Portal Vein “Y“ Graft in Anterior Sector Outflow Reconstruction in Adult Living Donor Right Lobe Grafts.

S. Kapoor, B. Nath, V. Varma, S. Sable, A. Chauhan, V. Kumaran.
Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.

M. Lim,¹ D. Sawinski,¹ J. Cohen,^1,2 B. Weiss,^3,4 J. Hogan,^1,3 L. Dember.^1,3
Patient Outcomes Following the Disappearance of Donor Specific Antibody in Crossmatch Positive Simultaneous Liver-Kidney Transplant Recipients.

P. Jindra,¹ G. Stacie,¹ A. Rana,² C. O'Mahony,² J. Goss,² M. Bhamidipati,² E. Whiston,³ R. Kerman.¹
Patient-Reported Barriers to the Pre-Kidney Transplant Evaluation in an At-Risk Population in the United States.

M. Lockwood,¹ W. Chon,² M. Josephson,² Y. Becker,² M. Saunders.²
Patients with Renal Failure Have a pERK-Dependent Defective TCR-Mediated Activation of CD4⁺ T Cells.

L. Huang, N. Litjens, N. Kannegieter, M. Klepper, C. Baan, M. Betjes.
Patterns and Associated Risk Factors for Early Readmissions Post Total Pancreatectomy and Islet Auto-Transplantation(TP-IAT).

V. Kirchner, A. Bagdiwala, D. Vock, M. Bellin, G. Beilman, L. Berry, S. Chinnakotla, T. Dunn, M. Freeman, D. Sutherland, T. Pruett.
Patterns of Monocyte Differentiation and Activation in a Non-Human Primate Model of Brain Death.

P. Chlebeck, J. Danobeitia, L. Zitur, T. Zens, X. Xu, S. Odorico, A. D'Alessandro, L. Fernandez.
Pediatric Liver Transplantation for Alpha-1 Antritrypsin Deficiency: A UNOS Database Analysis.

J. Jossen,¹ R. Annunziato,² J. McShane,² J. Chu,¹ R. Arnon.¹
Pediatric Recipients of Deceased Adult Donor Kidneys Have Equivalent Outcomes Compared with Pediatric Donors.

D. Mikhail,¹ H. Sharma,^3,4 J. Chen,² M. Cooper,⁴ A. Sener,^1,3 P. Luke.^1,3
Penis Transplantation: First U.S. Experience.

D. Ko, K. Li, H. Salinas, I. Schol, M. Treiser, F. McGovern, A. Feldman, B. Bojovic, J. Winograd, M. Grant, R. Ehrlichmann, C. Tanrikut, J. Lee, G. Choy, R. Liu, I. Rosales, R. Colvin, K. Eberlin, C. Cetrulo, Jr.
Perceived Legitimacy of Using Social Support for Transplant Eligibility: Results from a National Survey of Transplant Clinicians.

K. Ladin,¹ E. Gordon,² Z. Butt,² T. Lavelle,¹ N. Daniels,³ D. Hanto.⁴
Perceived Patient Barriers for Kidney Transplant Evalution Among Transplant Center Staff.

L. McPherson, K. Lipford, R. Hamoda, J. Gander, S. Pastan, R. Patzer.
Percentage of CD19⁺ B Cells as a Predictor of Acute Antibody-Mediated Rejection After Administration of Rituximab in ABO-Incompatible Kidney Transplantation.

T. Hirose, D. Iwami, K. Hotta, H. Sasaki, H. Higuchi, N. Shinohara.
Percutaneous Direct Intrahepatic Portosystemic Shunt as a Bridge to Liver Transplantation in Pediatric Patients with Variceal Bleeding.

D. Yoeli,¹ N. Galvan,¹ D. Ashton,² K. Kumm,¹ M. Kueht,¹ E. Witte,¹ T. Miloh,³ R. Cotton,¹ A. Rana,¹ C. O'Mahony,¹ J. Goss.¹
Performance Comparison of Barcoded Oligos and Standard qPCR on Matched FFPE and RNAlater-Submerged Human Kidney Allograft Samples.

T. Sigdel, M. Nguyen, D. Dobi, J. Liberto, S.-C. Hsieh, F. Vincenti, M. Sarwal, Z. Laszik.
Performance-Based vs. Self-Reported Functional Assessment on Outcomes After Kidney Transplant.

K. Tibaldi, N. Dhillon, R. Goldberg, H. Paniagua, A. Patel.
Persistence/Progression of Early Banff Borderline Changes (BBC) Is Associated with Chronic Renal Allograft Damage and Can Be Predicted by B Cell Cytokine Profile.

A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Persistent Donor Antigen Leads to Dysfunctional CD4⁺Memory T Cell Development.

M. Miller,¹ Y. Wang,¹ L. Chen,¹ Y. Lei,¹ M. Daniels,^2,3 E. Watkins,⁴ C. Mora Solano,² C. McIntosh,¹ N. Isaad,⁵ A. Chong,² M.-L. Alegre.¹
Persistent Hypophosphatemia Among Deceased-Donor Kidney Transplant Recipients Is Donor-Dependent and Associated with Superior Long-Term Allograft Outcomes.

N. Otto, T. Schachtner, P. Reinke.
Personalized Tacrolimus (TAC) Dosing Using Genetic Variants in Caucasian Kidney Transplant (Tx) Recipients.

D. Margraf,¹ R. Brundage,¹ D. Schladt,² W. Guan,³ B. Wu,³ R. Remmel,⁴ C. Dorr,^2,7 D. Berglund,¹ R. Mannon,⁵ A. Matas,⁶ W. Oetting,¹ A. Israni,^2,7 P. Jacobson,¹ For the DeKAF Genomics Investigators.
Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.

M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.
Pharmakokinetics of Daclatasvir, Sofosbuvir and GS-331007 in a Prospective Cohort of HCV Positive Kidney Transplant Recipients.

E. Schrezenmeier,¹ P. Galander,¹ F. Hoffmann,² C. Jaeger,² J. Lisec,² J. Schrezenmeier,² O. Staeck,¹ L. Lehner,¹ D. Khadzhynov,¹ F. Halleck,¹ M. Duerr,¹ K. Budde.¹
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes (T1D) Post Renal Transplantation.

J. Markmann, R. Alejandro, M. Bellin, N. Bridges, W. Clarke, T. Eggerman, E. Foster, B. Hering, D. Kaufman, O. Korsgren, X. Luo, A. Naji, J. Oberholzer, A. Posselt, M. Rickels, C. Ricordi, M. Robien, P. Senior, A. Shapiro, N. Turgeon.
Phenotypic and Functional Assessment of T Cell Alloimmunity After Liver Transplantation.

T. Taner, M. Hansen, W. Park, M. Stegall.
Photopheresis for Recalcitrant Rejection After Heart Transplantation: Worthwhile?

J. Patel, M. Kittleson, X. Zhang, E. Klapper, T. Aintablian, K. Murayama, L. Czer, D. Geft, D. Chang, J. Kobashigawa.
Pilot Study on Acupuncture in Living Liver and Kidney Donors.

M. Jesse, M. Kulas, J. Unitis, N. Beltran, M. Abouljoud.
Placental Leukocytes Are Maternally Derived: Implications for Pregnancy-Induced Alloimmunization.

P. Porrett,¹ E. Lewis,² R. Xu,¹ A. Brown,² E. Wherry,³ M. Elovitz.²
Plasma Cell Hepatitis in Primary Sclerosing Cholangitis Patients: 15-Year Experience at a Transplant Center.

J. Putra,¹ T. Schiano,² M. Fiel.³
Plasma Extracellular Vesicles MicroRNA Signatures Associate with Graft Function Recovery Post-Acute Renal Allograft Injury.

V. Bontha, A. Fernandez-Pineros, D. Bagchi, D. Maluf, E. Rhone, V. Mas.
Platelets Stimulate Liver Sinusoidal Endothelial Cells to Secrete Interleukin-6 During the Early Phase of Liver Regeneration in Mice.

J. Meyer,^1,2 E. Perroud,² P. Fontana,^3,4 K. Sadoul,⁵ P. Morel,^1,2 C. Gonelle-Gispert,² L. Bühler.^1,2
Podocyte Participates in the ST2 Related Renal Fibrosis.

Y. Kim,¹ S. Yang,^2,3 R. Cha,⁴ M.-Y. Yu,¹ S. Lee,³ H. Lee,¹ J. Lee,⁵ D. Kim,^1,3 S. Kim,³ Y. Kim.^1,2,3
Podocyte-Specific Knockdown of SHROOM3 Causes Albuminuria and Foot-Process Effacement by Interaction with FYN.

M. Menon, N. Philippe, C. Wei, W. Zhang, J. He, B. Murphy.
Polycystic Liver Disease Patients May Not Be Appropriately Represented by MELD Exception Policy.

S. Chandradas,¹ J. Waalen,² C. Frenette.¹
Polypharmacy and Frailty in Kidney Transplant Recipients.

H. Ying, M. McAdams-DeMarco, D. Segev.
Poor Outcome of Polyomavirus -Associated Nephropathy with Glomerular Parietal Epithelial Cells Infected by Polyomavirus.

G. Huang,¹ W. Chen,² J. Qiu,¹ X. Chen,¹ L. Chen,¹ C. Wang.¹
Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers.

B. Scully,¹ J. Heinle,¹ M. Kueht,¹ E. McKenzie,¹ G. Mallory,² E. Melicoff,² A. Rana.¹
Poor Predictability of Quantiferon-TB Assay in Recipients and Donors for Tuberculosis Development After Kidney Transplantation in an Intermediate-TB-Burden Country.

J. Yang,¹ J. Ryu,¹ J. Jang,² J.-G. Lee,² C. Ahn.¹
Poor Prediction of Rejection and Kidney Survival by Donor-Specific-Antibodies Characterization.

L. Couzi,^1,2,3 M. Courant,¹ J. Visentin,^1,2,3 V. Dubois,⁴ S. Lepreux,^1,2 G. Guidicelli,¹ O. Thaunat,^5,6 P. Merville,^1,2,3 J.-L. Taupin.⁷
Population Pharmacokinetic Profiling of Tacrolimus in Renal Transplant Recipients (RTRs) Taking Diltiazem.

P. Trevillian,^1,2,3 M. Heer,^1,2 S. Ainsworth,¹ A. Hibberd.^1,2,3
Porcine Albumin Elaboration During Perfusion of Transgenic Porcine Livers with Human Blood.

A. Cimeno,¹ J. Powell,¹ B. French,¹ D. Ayares,² A. Azimzadeh,¹ R. Pierson III,¹ R. Barth,¹ J. LaMattina.
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.

M. George, G. Thomas, A. Shun.
Positive Flow Crossmatch After Negative Virtual Crossmatch -A Single Center Experience.

Q. Xu, S. Leckie.
Post Transplant Outcomes in Hepatitis C Positive Patients.

M. Lubetzky, N. Hayde, L. Kamal, M. Ajaimy, P. Bedi, G. Deboccardo, J. Rocca, S. Greenstein, J. Graham, A. Chokechanachaisakul, A. Courson, M. Kinkhabwala, E. Akalin.
Post-Donation Experiences of Non-Directed (Altruistic) Living Kidney Donors in the United States.

A. Maghen,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² L. Kwan,¹ S. Maliski,³ J. Veale.
Post-Donation GFR Changes in Living Kidney Donors.

E. Poggio,¹ S. Arrigain,² J. Augustine,¹ S. Flechner,³ J. Schold.²
Post-Donation Remaining Donor Kidney Function as Measured by CKD-EPI Formula at 2 Years Correlates and Is Predicted by Remaining Donor Kidney Volume.

S. Hussain, A. Diez, A. Khalil, M. Yaqub, D. Mishear, T. Taber, O. Adebiyi, C. Sundaram, W. Goggins, J. Powelson, A. Sharfuddin.
Post-Liver Transplant (LT) Early Allograft Dysfunction (EAD) Modulates the Effect of Pre-LT Kidney Function on Post-LT Survival.

H. Wadei, M. Mai, B. Taner, K. Croome, A. Keaveny, L. Mai, D. Lee.
Post-Transplant Graft Function Is Associated with Major Cardiovascular Events in Kidney Transplant Recipients: A Multicenter Cohort Study.

J. Park,¹ Y. Kim,² S. Yang,³ S. Park,² S.-K. Park,⁴ D. Han,⁵ Y. Kim,² Y. Kim,⁵ J. Lee.⁶
Post-Transplant Lymphoproliferative Disorder: Risk Analysis for Pancreas Transplant Patients.

E. Minja, T. Dunn, A. Matas, T. Pruett, R. Kandaswamy, E. Finger.
Post-Transplant Reduction in Pre-Existing Donor-Specific Antibody Levels After Belatacept- vs Cyclosporine-Based Immunosuppression.

R. Bray,¹ H. Gebel,¹ R. Townsend,² M. Polinsky,² L. Yang,² U. Meier-Kriesche,² C. Larsen.¹
Post-Transplant Sensitization: Does it Make a Difference in the Development of First-Year Intimal Thickening?

J. Patel, M. Kittleson, L. Czer, T. Aintablian, E. Stimpson, B. Azarbal, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.
Post-Transplant Urinary Transglutaminase 2 Is a Potent Biomarker to Predict Kidney Allograft Inflammation or Fibrosis.

S. Shin,¹ Y.-M. Wee,¹ M. Choi,¹ Y. Cho,² H. Go,² Y. Kim,¹ D. Han.¹
Postoperative Serum Lactate Dehydrogenase Is a "Troponin-Like" Marker of Renal Transplant Distress.

R. Steiner, J. Halldorson.
Posttransplant Employment Patterns Are More Favorable in Patients with Solitary Pancreas vs. Simultaneous Pancreas/Kidney (SPK) Transplants – The Impact of Native Kidney Function.

S. Gruessner.
Potential Barriers Hindering Non-Directed (Altruistic) Living Kidney Donors from Donating Their Kidneys.

A. Maghen,¹ L. Kwan,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² S. Maliski,³ J. Veale.
Potential Living Kidney Donors (LKD) Concerns About Opting Out and Preferences for an 'Alibi'.

K. Yu,¹ C. Thiessen,¹ S. Li,¹ D. Dobosz,¹ J. Gannon,¹ K. Kennedy,² D. Gray,³ A. Mussell,³ P. Reese,³ S. Kulkarni,¹ E. Gordon.²
Potential Mechanism Involving Regulatory T Cells in Induction of Tolerance in Mouse Vascularized Composite Allotransplantation Under Combined Costimulation Blockade.

M. Anggelia,^1,2 Y.-Y. Huang,³ W.-Y. Chuang,⁴ H.-Y. Cheng,¹ G. Brandacher,⁵ F.-C. Wei,^1,2 C.-H. Lin.^1,2
PPAR-γ Agonist Attenuates Hepatic Ischemia-Reperfusion Injury in a Mouse Model by Regulating Kupffer Cell Polarization.

I. Linares, K. Farrokhi, J. Echeverri, M. Kaths, D. Kollman, M. Hamar, P. Urbanellis, S. Ganesh, O. Adeyi, P. Yip, N. Selzner, M. Selzner.
Practice Patterns in the Treatment and Monitoring of Acute Cell-Mediated Kidney Graft Rejection in Canada.

J. Leblanc,¹ P. Subrt,² M. Paré,³ D. Hartell,⁴ L. Sénécal,⁵ T. Blydt-Hansen,⁶ H. Cardinal.¹
Pre Transplant Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipient on Steroid Free Maintenance Immunosupression Regimen.

O. Adebiyi,¹ A. Sharfuddin,² M. Yaqub,¹ S. Hussain,¹ D. Mishler,¹ A. Sharfuddin,¹ W. Goggins,¹ T. Taber.¹
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.

A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
Pre-OLT CKD-3 Increases Post-OLT ESRD and AKI Impacts Early Post-OLT Survival.

G. Faddoul, L. Liriano-Ward, P. Chang, Y. Azzi, K. Chauhan, G. Nadkarni, V. Nair, R. Kent, S. Lerner, S. Coca, P. Heeger, S. Florman, S. Thomas, M. Menon.
Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.

M. Fujiki,¹ K. Hashimoto,¹ A. Zhang,² F. Aucejo,¹ C. Quintini,¹ T. Diago,¹ B. Eghtesad,¹ C. Miller.¹
Pre-TACE Immune Status Correlates with Treatment Response and Tumor Biology in HCC as a Bridge to Transplant.

T. Sandow,¹ H. Bohorquez,² D. Kirsch,¹ A. Albar,¹ P. Thevenot,³ K. Nunez,³ D. DeVun,¹ J. Gimenez,¹ G. Galliano,⁴ A. Cohen,² G. Loss,² D. Kay,¹ P. Gulotta.¹
Pre-Transplant Circulating TNFR2+ Regulatory T Cells Predict Acute Rejection within the First 6 Months After Kidney Transplantation.

M.-T. Nguyen,¹ S. Sahakian,² S. Liu,² Y. Wang,² J. Tchervenkov,² S. Paraskevas.²
Pre-Transplant CMV-Specific T-Cell Immunity Is an Additional Independent Variable Predicting CMV Infection After Kidney Transplantation.

E. Crespo,¹ M. Jarque,¹ S. Luque,¹ E. Melilli,² A. Manonelles,² S. Gil-Vernet,² J. Cruzado,² J. Grinyó,² O. Bestard.²
Pre-Transplant Evaluation of KSORT^SM to Assess Risk for Rejection in Highly Sensitized Patients.

S. Nandoe,¹ S. Roedder,³ S. Hsieh,¹ T. Sigdel,¹ P. Lindner,⁴ J. Ekberg,⁴ J. Alberu,⁵ F. Vincenti,¹ M. Sarwal.¹
Pre-Transplant HLA-Specific B Cell Breadth of Reactivity in a Novel Multiplex Bead-Based Assay Predicts Rejection in Kidney Transplant Recipients.

Z. Ilyas,¹ A. Aki,¹ A. Tambur,¹ P. Heeger,² M. Ansari.¹
Pre-Transplant Non-Cytotoxic Donor Specific HLA Antibodies Do Not Increase the Risk of Graft Dysfunction in Kidney Transplant Recipients with Thymoglobulin and IVIG Induction.

A. Colovai, M. Ajaimi, N. Hayde, L. Kamal, S. Chan, C. Savchik, J. Rocca, E. Akalin.
Pre-Transplant Panel Reactive T Cells (PRT) with IL-15 as a Risk-Stratifier of Acute Rejection in Kidney Transplant Patients on Belatacept Therapy.

P. Cravedi,¹ I. Gandolfini,¹ C. Donadei,¹ R. Fairchild,² K. Newell,³ R. Mannon,⁴ P. Heeger,¹ CTOT16 Consortium.
Pre-Transplant Recipient Transcriptomic Profile May Predict Delayed Graft Function (DGF) in Kidney Transplantation.

P. Pontrelli,¹ F. Rascio,² F. Pesce,¹ M. Accetturo,¹ G. Castellano,¹ G. Zaza,³ A. Lupo,³ M. Fiorentino,¹ L. Gesualdo,¹ G. Stallone,² G. Grandaliano.²
Preceeding the Rejection: Clinical Results of a Saliva Test After Renal Transplantation.

D. Abendroth,¹ M. Marzinzig,¹ M. Stangl.²
Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching.

D. Li,¹ O. Timofeeva,¹ M. Awwad,¹ C. Cody,² S. Najjar,² S. Rosen-Bronson.¹
Predicting Immunologic Risk for Acute Rejection in Pediatric Liver Transplantation.

S. Antala, L. Bow, R. Morotti, G. Gan, D. Yanhong, U. Ekong, S. Emre.
Predicting Recurrence Prior to Transplant: The Response of HCC to Chemoembolization.

T. Sandow,¹ H. Bohorquez,² D. Kirsch,¹ P. Thevenot,³ K. Nunez,³ A. Albar,¹ D. DeVun,¹ J. Gimenez,¹ G. Galliano,⁴ A. Cohen,² G. Loss,² D. Kay,¹ P. Gulotta.¹
Predicting Residual Renal Compensation in Living Kidney Donors Post-Donation.

A. Diez, G. Diltz, J. Von Visger, U. Nori, T. Pesavento, R. Pelletier.
Prediction of Delayed Graft Function in Chinese Kidney Allograft Recipients.

H. Zhang, S. Qin, L. Zheng, L. Liu, C. Wang.
Prediction of Evolution Toward Brain Death in Acute Neurocritical Patients Identified as Potential Organ Donors.

G. Xu, P. Xu, Z. Guo, X. He.
Prediction of Positive Cytotoxic and Flow Crossmatches for Sensitized Wait List Candidates: Comparison of Luminex MFI, C1q and FcR Binding Assays.

A. Girnita, E. Woodle.
Prediction of Renal Allograft Acute Rejection Using a Novel Non-Invasive Model Based on Acoustic Radiation Force Impulse.

C. Yang,¹ Y. Jin,² S. Wu,³ T. Zhu,¹ W. He.²
Predictive Value of Post Reperfusion TEG in Peri-Operative Outcomes During Liver Transplant.

P. Sheiner, A. Sulejamnovic, J. Salm, E. Silver, C. Rochon.
Predictive Value of Pre-Transplant Cross-Match Techniques on Living Donor Kidney Transplant Outcomes.

M. Meneghini,¹ E. Melilli,¹ I. Revuelta,³ R. Rajalingam,² E. Rigol,⁴ S. Chandran,² F. Diekmann,³ F. Vincenti,² J. Cruzado,¹ J. Martorell,⁴ O. Bestard.¹
Predictive Value of Renal Poly (ADP-Ribose) Polymerase (PARP) Expression Both in Inflammation and Interstitial Fibrosis Processes in Recipients with Antibody-Mediated Rejection.

B. Ozdemir,¹ F. Ozdemir,² E. Baskin,² M. Haberal.³
Predictive Value of Renal Transplant Scintigraphy for the Duration of Delayed Graft Function.

S. Benjamens,^1,2 R. Pol,¹ A. Glaudemans,² S. Berger,³ R. Slart.²
Predictive Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy After Kidney Transplantation.

N. Maillard,¹ H. Suzuki,² H. Mohey,¹ C. Mariat,¹ J. Novak,³ B. Julian,⁴ F. Berthoux.¹
Predictors of Graft Loss in an Urban Predominantly Minority Cohort of Kidney Transplant Recipients.

N. Hayde, L. Kamal, M. Ajaimy, M. Lubetzky, P. Bedi, G. de Boccardo, E. Akalin.
Predictors of Malignancies Across Solid Organ Transplantation.

M. Bhat,¹ K. Mara,² R. Dierkhising,² K. Watt.³
Predictors of Renal Function Compensation in Live Donor Nephrectomy.

J. Choong, H. Ali, A. Ahmed.
Predictors of Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients.

A. Ruiz, K. Smith, J. Wedd, K. Little, S. Pastan, R. Patzer.
Preformed HLA Donor-Specific Antibodies Disappearance After Kidney Transplantation: Significance and Comparison with Persistent DSA.

D. Redondo,¹ M. Pérez-Sáez,¹ M. Mir,¹ J. Gimeno,¹ C. García,² J. Hernández,² J. Yélamos,³ J. Pascual,¹ M. Crespo.¹
Pregnancy After Kidney-Pancreas Transplantation: Maternal and Offspring Outcomes.

S. Rao,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^1,2 M. Moritz.^2,3,4
Pregnancy Outcomes in Female Kidney Transplant Recipients Using Assisted Fertility Methods.

L. Coscia,¹ D. Armenti,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
Pregnandy During Kidney Trasplantation in a Low Income Population.

M. Taylor, M. Torres, D. Silvia, L. Martínez, H. Petrone.
Preliminary Results of Clinical Normothermic Ex Vivo Liver Perfusion in a North American Setting.

M. Bral,¹ B. Gala-Lopez,¹ D. Bigam,¹ N. Kneteman,¹ A. Malcolm,¹ S. Livingstone,¹ A. Andres,¹ J. Emamaullee,¹ L. West,¹ P. Friend,² A. Shapiro.¹
Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.

S. Biswas Roy,¹ M. Olson,² D. Harned,¹ P. Kang,³ R. Panchanathan,³ A. Hashimi,¹ J. Huang,¹ H. Abdelrazek,¹ V. Patel,¹ A. Omar,¹ R. Bremner,¹ M. Smith,¹ R. Walia,¹ A. Kalya.⁴
Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

K. Lentine,¹ N. Lam,² D. Segev,³ D. Axelrod,⁴ Z. Zhang,¹ H. Xiao,¹ G. Hess,⁵ B. Kasiske,⁶ R. Gadi,¹ R. Devraj,⁷ D. Brennan,⁸ H. Randall,¹ M. Schnitzler.^1,6
Presence of Anellovirus Nucleic Acid Sequences in Involved Tissue Is Associated with Worse Patient Survival in Post-Transplant Lymphoproliferative Disorder.

V. Dharnidharka, R. Chen, M. Ruzinova, P. Parameswaran, H. O'Gorman, K. Wylie, G. Storch.
Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study.

A. Babu,^1,4,5 O. Shaw,² L. Howe,² N. Kessaris,³ A. Dorling,³ N. Mamode,³ R. Vaughan,² N. Krishnan,⁵ R. Higgins,⁵ D. MItchell,¹ D. Briggs,⁴ S. Daga.^1,5,6
Preservation of Musculoskeletal Components in Vascularized Composite Allograft Skin Rejection.

E. Buckingham, A. Khalifeh, M. Uluer, W. Hassenein, C. Drachenberg, A. Nam, W. Twaddell, S. Bartlett, R. Barth.
Preservation Solution Affects the Immunological Milieu in Lung Transplantation and Alters the Inflammatory Balance.

R. Bellmàs Sanz,¹ M. Seyda,¹ B. Wiegmann,² C. Neudoerfl,¹ A. Haverich,^2,3 C. Falk,^1,4 G. Warnecke.^2,3
Prevalence and Clinical Outcomes in Kidney Transplant Patients with Viral and Fungal Opportunistic Infections and Malignancy.

M. Lubetzky, N. Hayde, L. Kamal, M. Ajaimy, P. Bedi, G. Deboccardo, E. Akalin.
Prevalence of Cutaneous Disease in Solid Organ Transplant Recipients: A 5-Year Study from a Medical -Surgical Transplant Dermatology Center.

R. Allawh, A. Weiffenbach, K. Nadhan, M. Abdelmalek, C. Cusack, C. Chung.
Prevalence of CYP3A Genomic Variances and Impact on Tacrolimus Dosing Requirements in Kidney Transplant Recipients in Eastern North Carolina.

T. Asempa,¹ S. Hudson,² L. Rebellato,² A. Maldonado.¹
Preventing Alloimmune Rejection in Heart Transplantation by Tolerogenic Dendritic Cells Induced by GDF15 Through Up-Regulation of IDO and Inhibition of the NFκB Signalling Pathway.

Y. Zhang,^1,3 G. Zhang,¹ L. Moszczynski,¹ D. Zhao,^1,3 P. Abulizi,¹ D. Quan,² T. Mele,² K. Liu,³ X. Zheng.^1,2
Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism.

B. Oh,¹ C. Cheng,² G. Furtmüller,¹ W. Lee,¹ J. Powell,² G. Brandacher.¹
Prevention of Donor Specific Antibody Production After Skin Allografting by Mobilization of Endogenous Stem Cells Using a Combination of AMD3100 and Low-Dose FK506 in Rats.

A. Ahmadi,¹ L. Qi,¹ R. Wesson,¹ F. Dor,² J. Burdik,¹ B. Philosophe,¹ G. Williams,¹ A. Cameron,¹ Z. Sun.¹
Primary Graft Dysfunction After Pediatric Heart Transplant.

K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.
Primary Graft Dysfunction Post Heart Transplantation: Is There Greater Risk for De Novo Donor-Specific Antibody Development?

J. Patel, M. Kittleson, L. Czer, T. Aintablian, T. Kao, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.
Primary Hyperoxaluria Type-1 in Chinese Population: A Case Series and Review of Literature.

D. Du,^1,2 Q. Li,^1,2 H. Shi,^1,2 S. Chen,^1,2 B. Liu,^1,2 Z. Lin,^1,2 G. Chen,^1,2 F. Zeng,^1,2 W. Zhang,^1,2 Z. Chen.^1,2
Primary Urtero- Ureterostomy in Renal Transplant, an Old Forgotten but Promising Technique.

H. Shokouh-Amiri, G. Zibari, S. Ahmadzadeh, R. Poudel, D. Aultman, H. Samant, N. Singh.
Prioritization for Kidney Transplant Due to Medical Urgency: Clinical Characteristics and Outcomes After Transplantation.

J. Oliveira,¹ T. Sandes-Freitas,^1,2 M. Oliveira,¹ L. Mesquita,² G. Dantas,² E. Daher,² R. Esmeraldo.¹
Pro Inflammatory Transitional B (TrB) Cells Characterize Renal Allograft Recipients with DSA and T Cell Mediated Rejection (TCMR).

A. Sharma, A. Cherukuri, D. Rothstein.
Procurement Kidney Biopsy versus KDRI for Predicting Graft Survival.

I. Hall,¹ C. Parikh,² B. Schröppel,³ F. Weng,⁴ Y. Jia,² H. Thiessen-Philbrook,² P. Reese,⁵ M. Doshi.⁶
Prognostic Histopathologic Characteristics in Recurrent IgA Nephropathy: The Clinical Significance of Vascular Change.

S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.
Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratio in Patients Undergoing Liver Transplantation with Hepatocellular Carcinoma within Milan Criteria.

S.-K. Kwon,¹ J. Lee,¹ S. Song,¹ J. Lee,¹ D. Kim,¹ J. Lee,² M. Kim,¹ G. Choi,¹ J. Choi,¹ D. Han,¹ S. Kim,¹ D. Joo.¹
Prognostic Tools to Choose Candidates for Successful Desensitization.

D. Pinelli,¹ A. Zachary,² J. Friedewald,¹ M. Leffell,² D. Lucas,² R. Montgomery,² A. Tambur.¹
Program-Specific Offer Acceptance Behavior for Kidney Programs Across the Spectrum of KDPI.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Prolonged Cold Ischemia Time as a Risk for Low Regeneration at the Early Phase After Living Donor Liver Transplantation.

K. Takahashi,^1,2 S. Nagai,¹ M. Safwan,¹ K. Putchakayala,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ G. Schnickel,¹ M. Abouljoud.¹
Prolonged Dialysis Prior to Renal Transplantation.

D. Aufhauser Jr,¹ A. Peng,¹ D. Murken,¹ S. Concors,¹ M. Levine.^1,2
Prolonged Liver Ischemia Triggers Necrotic Depletion of TIM4+ Kupffer Cells to Facilitate Tissue Inflammatory Immune Activation in Liver Ischemia-Reperfusion Injury.

H. Wang,¹ S. Yue,¹ M. Ni,¹ R. Busittil,¹ J. Kupiec-Weglinski,¹ L. Lu,² Y. Zhai.¹
Prolonged Survival with Co-Stimulatory Blockade Based Immunosuppression in Pig-to-Primate Liver Xenotransplantation.

J. Shah, M. Patel, N. Elias, I. Rosales, N. Navarro-Alvarez, M. Hertl, A. Cosimi, R. Colvin, J. Markmann, D. Sachs, P. Vagefi.
Prominence of Graft-Infiltrating PD-L1^hi Cross-Dressed Dendritic Cells in Mouse Liver Transplant Tolerance.

Y. Ono, A. Perez Gutierrez, S. Yokota, O. Yoshida, T. Nakao, G. Camirand, D. Geller, A. Thomson.
Propensity-Matched Comparison of Diabetic Patients and Non-Diabetic Patients in Living Donor Kidney Transplantation.

C. Baek,¹ H. Kim,¹ W. Yang,¹ D. Han,² S.-K. Park.¹
Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.

A. Kashem,¹ S. Keshavamurthy,¹ J. Gomez-Abraham,¹ T. Yoshizumi,¹ H. Zhao,² F. Cordova,³ G. Criner,³ Y. Toyoda.¹
Prophylactic Therapy Against Multidrug-Resistant Acinetobacter baumannii Contamination of Preservation Solution in Renal Transplantation: A Single Center Experience.

R. Wang, J. Zhou, J. Wu.
Proposal for HCC Exception Points to Match Drop Out Risk.

H. Yeh,³ M. Akan,¹ N.-H. Leung,² J. Markmann,³ S. Tayur.¹
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.

S. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ R. Saxena,² N. Rush,² N. Higgins,⁴ M. Ghabril,³ M. Lacerda,³ A. Lobashevsky.⁴
Prospective Monitoring of 25-Hydroxyvitamin Vitamin D Levels After Kidney Transplantation and Its Associations with Clinical Outcomes.

P. Bedi, N. Hayde, L. Kamal, M. Ajaimy, M. Lubetzky, G. de Boccardo, E. Akalin.
Prospective Monitoring of De Novo Donor-Specific Antibodies: Incidence, Clinical Outcomes and Dynamic Changes Over 5 Years After Kidney Transplantation.

M. Ajaimy, A. Colovai, N. Hayde, J. Graham, M. Lubetzky, L. Kamal, G. De Bocardo, E. Akalin.
Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin (rATG) 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-Free and CNI Minimization Maintenance Immunosuppressive Regimen.

T. Sandes-Freitas, J. Junqueira, Jr, C. Girão, M. Oliveira, R. Esmeraldo.
Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.

M. Jarque,² E. Melilli,¹ A. Gutierez,³ F. Moreso,⁴ L. Guirado,⁵ A. Manonelles,¹ J. Cruzado,^1,2 S. Luque,² E. Crespo,² N. Montero,¹ F. Diekman,⁶ J. Grinyó,^1,2 O. Bestard.¹
Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients.

B. Shelton,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ J. Locke.¹
Proteasome Modulation an Effective Strategy to Ameliorate Steatotic Liver Grafts Viability After Preservation.

M. Zaouali,¹ A. Panisello Roselló,¹ T. Carbonell,² A. Garcia-Gil,³ A. Lopez,⁴ R. Adam,⁴ J. Rosello-Catafau.¹
Protective Effect of Crepidiastrum denticulatum Extract Pretreatment Against Hepatic Ischemia-Reperfusion Injury in Mice.

H. Jang, H. Lee, C. Park, D. Eom, J. Lee, M. Oh, J. Yoo, C. Rho.
Protective Effect of New Delivery System of Nitric Oxide Releasing Nanofiber in Rat Model of Renal Ischemia-Reperfusion Injury.

J. Kim,¹ H. Ahn,² D. Kim,¹ S. Jung,¹ E. Park,¹ T. Lee,¹ C. Ihm,¹ S. Lee,¹ J. Moon,¹ Y. Kim,¹ K. Jeong.¹
Protective Effects of Bryostatin-1 on Neutrophil Migration in an In Vitro Model of Ischemia Reperfusion Injury: Impact for Therapy.

F. Becker,¹ L. Kebschull,¹ T. Castor,³ D. Palmes,² S. Alexander,² F. Gavins.²
Proteins in Preservation Fluid Predict Delayed Graft Function of Kidneys from Donors After Circulatory Death.

B. van Balkom,¹ H. Gremmels,¹ L. Ooms,⁴ R. Toorop,² F. Dor,⁵ O. de Jong,¹ L. Michielsen,¹ G. de Borst,² W. de Jager,³ A. van Zuilen,¹ M. Verhaar.¹
Proteomic Profiles of Deceased Donor Kidney Biopsies Obtained Prior to Transplantation Correlate with Allograft Function at One Year.

M. Kaisar,^1,2 L. van Dullemen,¹ Z. Akhtar,¹ H. Huang,¹ B. Kessler,² R. Ploeg.¹
Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.

K. Bornemann,¹ E. Croswell,¹ M. Abaye,¹ C. Bryce,¹ J. Chang,^1,2 D. Good,³ C. Freehling Heiles,³ M. Dew,¹ L. Boulware,⁴ A. Tevar,^1,3 L. Myaskovsky.^1,2
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient and Allograft Survival in Long-Term Follow-Up After Kidney Transplantation.

T. Schachtner,^1,2,3 P. Reinke.^1,2
Psychosocial Distress in Chronic Kidney Disease: Benefits of Kidney Transplantation.

C. Richardson,¹ D. Belenko,¹ E. Mucsi,¹ N. Edwards,¹ D. Wong,¹ M. Novak,² M. Li,³ I. Mucsi.¹
PTEN Inhibition in MSC Upregulates PD-L1 and Enhances Their Immunomodulatory Capacity Prolonging Skin Allograft Survival.

M. Climov, M. Uehara, Z. Solhjou, H. Matsumine, N. Bouyani, E. Kefaloyianni, B. Basmani, V. Kasinath, G. Giatsidis, D. Orgill, R. Abdi.
Pulse Pressure After Renal Transplantation – Influence on Outcome: Results from the Collaborative Transplant Study.

B. Krüger,¹ B. Döhler,² B. Krämer,¹ C. Süsal.²